OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 26 filers reported holding OPIANT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $784,410 | +87.7% | 38,679 | -0.6% | 0.00% | – |
Q3 2022 | $418,000 | -6.9% | 38,924 | +4.0% | 0.00% | – |
Q2 2022 | $449,000 | -43.5% | 37,426 | +0.9% | 0.00% | – |
Q1 2022 | $794,000 | -37.6% | 37,078 | -2.0% | 0.00% | – |
Q4 2021 | $1,273,000 | +30.4% | 37,850 | -0.1% | 0.00% | – |
Q3 2021 | $976,000 | +92.5% | 37,898 | -0.2% | 0.00% | – |
Q2 2021 | $507,000 | +47.8% | 37,958 | +17.6% | 0.00% | – |
Q1 2021 | $343,000 | -17.3% | 32,290 | -37.5% | 0.00% | – |
Q4 2020 | $415,000 | -7.2% | 51,634 | -13.6% | 0.00% | – |
Q3 2020 | $447,000 | -13.9% | 59,731 | +4.1% | 0.00% | – |
Q2 2020 | $519,000 | +15.1% | 57,383 | +21.9% | 0.00% | – |
Q1 2020 | $451,000 | -32.8% | 47,080 | +1.0% | 0.00% | – |
Q4 2019 | $671,000 | +3.7% | 46,605 | +8.5% | 0.00% | – |
Q3 2019 | $647,000 | +13.7% | 42,965 | 0.0% | 0.00% | – |
Q2 2019 | $569,000 | +0.9% | 42,965 | 0.0% | 0.00% | – |
Q1 2019 | $564,000 | -6.6% | 42,965 | +2.8% | 0.00% | – |
Q4 2018 | $604,000 | -16.3% | 41,803 | +3.5% | 0.00% | – |
Q3 2018 | $722,000 | +106.3% | 40,405 | +65.8% | 0.00% | – |
Q2 2018 | $350,000 | – | 24,372 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Independence Bank of Kentucky | 100 | $1,000 | 0.00% |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 4,429 | $63,000 | 0.00% |
ROYCE & ASSOCIATES LP | 431 | $6,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 6,418 | $92,000 | 0.00% |
BlackRock Inc. | 6,734 | $97,000 | 0.00% |
ROYAL BANK OF CANADA | 3,788 | $55,000 | 0.00% |
Gradient Investments LLC | 350 | $5,000 | 0.00% |
VANGUARD GROUP INC | 84,281 | $1,204,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 455 | $9,000 | 0.00% |
UBS Group AG | 1,984 | $28,000 | 0.00% |